Biosynthesis and action of neurosteroids

Brain Research Reviews

Volumn 37, Issue 1-3, 2001, Pages 3-12

  Mellon, Synthia H ^a   Griffin, Lisa D ^a   Compagnone, Nathalie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholinergic neuron; Gene expression; Neurodegenerative disease; Neurosteroid; NP C; P450c17; P450scc; Transcription

Indexed keywords

17 HYDROXYPREGNENOLONE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 5ALPHA DIHYDRODEOXYCORTICOSTERONE; 5ALPHA PREGNANE 3,20 DIONE; ALDOSTERONE; ANDROGEN; ANDROSTANEDIOL; ANDROSTENEDIOL; AROMATASE; CELL NUCLEUS RECEPTOR; CHOLESTEROL; CORTICOSTERONE; CORTODOXONE; CYTOCHROME P450; DEOXYCORTICOSTERONE; ESTRADIOL; ESTRONE; GLUCOCORTICOID; HYDROCORTISONE; ION; NEUROSTEROID; NEUROTRANSMITTER RECEPTOR; PRASTERONE; PREGNENOLONE; PROGESTERONE; STEROID 5ALPHA REDUCTASE; STEROID HORMONE; STEROID RECEPTOR; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL MODEL; BIOSYNTHESIS; BRAIN; BRAIN REGION; CELL TYPE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME CHEMISTRY; GENE EXPRESSION REGULATION; GONAD; HORMONE ACTION; HUMAN; NERVE FUNCTION; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; STEROIDOGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION; HUMANS; NERVOUS SYSTEM; NEURONS; RECEPTORS, NEUROTRANSMITTER; STEROIDS;

EID: 0035663507     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(01)00109-6     Document Type: Conference Paper

References (72)

1. 5 Alpha-pregnan-3 alpha,20 alpha-diol behaves like a partial agonist in the moduclation of GABA-stimulated chloride ion uptake by synaptoneurosomes
2. Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex
3. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one induces cytoarchitectural regression in cultured fetal hippocampal neurons
4. Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis
5. Differential distribution of the 5α-reductase in the central nervous system of the rat and mouse: Are the white matter structures of brain target tissue testosterone actions?
6. The 5 alpha-reductase in the brain: Molecular aspects and relation to brain function
7. Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis
8. Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system
9. Dehydroepiandrosterone: A potential signalling molecule for neocortical organization during development
10. Neurosteroids: Biosynthesis and function of these novel neuromodulators
11. Expression of steroid sulfatase during embryogenesis
12. Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis
13. Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery
14. Modulation of gamma-aminobutyric acid (GABA) receptors and the feeding response by neurosteroids in Hydra vulgaris
15. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain
16. Pregnenolone and its sulfate ester in the rat brain
17. Withdrawal from the endogenous steroid progesterone results in GABAA currents insensitive to benzodiazepine modulation in rat CA1 hippocampus
18. Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal
19. The neurosteroid, 3 alpha-hydroxy-5 alpha-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats
20. Ontogenesis of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in the rat adrenal as revealed by immunocytochemistry and in situ hybridization
21. Comparative effects of progesterone and alphaxalone on aggressive, reproductive and locomotor behaviors
22. The neurosteroid 3 alpha, 5 alpha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy
23. Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha,5 alpha-THP
24. Androgenic neurosteroids: Anti-seizure effects in an animal model of epilepsy
25. Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: A possible rat model of PMS anxiety
26. Transcriptional regulation of rat cytochrome P450c17 expression in mouse Leydig MA-10 and adrenal Y-1 cells: Identification of a single protein that mediates both basal and cAMP-induced activities
27. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
28. A key enzyme in the biosynthesis of neurosteroids, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase (3 beta-HSD), is expressed in rat brain
29. Progesterone metabolism in the pineal, brain stem, thalamus and corpus callosum of the female rat
30. Modulation of GABA receptor complex by a steroid anesthetic
31. Neurosteroids: Oligodendrocyte mitochondria convert cholesterol to pregnenolone
32. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus
33. Neurosteroids: Biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells
34. Neuroendocrine metabolism of progesterone and related progestins
35. Distribution of 3 alpha-hydroxysteroid dehydrogenase in rat brain and molecular cloning of multiple cDNAs encoding structurally related proteins in humans
36. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3 alpha-hydroxysteroid dehydrogenases
37. Ontogeny of 5 alpha-reductase (type 1) messenger ribonucleic acid expression in rat brain: Early presence in germinal zones
38. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
39. Differential localization of the 5 alpha-reductase and the 3 alpha-hydroxysteroid dehydrogenase in neuronal and glial cultures
40. Progesterone 5-alpha-reduction in neuronal and in different types of glial cell cultures: Type 1 and 2 astrocytes and oligodendrocytes
41. Neurosteroids: Biochemistry, modes of action, and clinical relevance
42. Neurosteroid biosynthesis: Genes for adrenal steroidogenic enzymes are expressed in the brain
43. Neurosteroids: Expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system
44. Immunocytochemical localization and biological activity of 3 beta-hydroxysteroid dehydrogenase in the central nervous system of the frog
45. The adrenal cortex
46. Progesterone withdrawal. I: Pro-convulsant effects
47. Lysosome lipid storage disorder in NCTR-BALB/c mice. I. Description of the disease and genetics
48. Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: Evidence for multiple steroid recognition sites
49. Localization of Niemann-Pick C1 protein in astrocytes: Implications for neuronal degeneration in Niemann-Pick type C disease
50. Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes
51. Niemann-Pick type-C disease: Deficient intracellular transport of exogenously derived cholesterol
52. Deficiencies in sex-regulated expression and levels of two hepatic sterol carrier proteins in a murine model of Niemann-Pick type C disease
53. The murine Niemann-Pick type C lesion affects testosterone production
54. Effects of antidepressant treatment on neuroactive steroids in major depression
55. Soporific effect of the neurosteroid pregnanolone in relation to the substance's plasma level: A pilot study
56. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (metrazol)
57. Correlations between the chemical structure and the pharmacological actions of the steroids
58. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
59. Premenstrual syndromes
60. Effect of fluoxetine on menstrual cycle length in women with premenstrual dysphoria
61. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group
62. Intracellular cholesterol trafficking
63. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography
64. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine
65. Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol
66. Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one
67. Ku autoimmune antigen is involved in placental regulation of rat P450c17 gene transcription
68. The orphan nuclear receptor steroidogenic factor-1 regulates the cAMP-mediated transcriptional activation of rat cytochrome P450c17
69. Multiple orphan nuclear receptors converge to regulate rat P450c17 gene transcription: Novel mechanism for orphan nuclear receptor action
70. Transcriptional regulation of P450scc gene expression in neural and in steroidogenic cells: Implications for regulation of neurosteroidogenesis
71. Polyribonucleotide phosphorylase is a double-stranded DNA-binding protein